Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA2B | P29275 | 3/20 | 0.48 |
| ▸ | ADORA2A | P29274 | 2/20 | 0.48 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.39 |
| ▸ | TSHR | P16473 | 3/20 | 0.39 |
| ▸ | PDE1A | P54750 | 2/20 | 0.39 |
| ▸ | PDE1B | Q01064 | 2/20 | 0.39 |
| ▸ | PDE1C | Q14123 | 2/20 | 0.39 |
| ▸ | BLM | P54132 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 2/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.39 |
| ▸ | PDE5A | O76074 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | EGFR | P00533 | 3/20 | 0.38 |
| ▸ | PDE2A | O00408 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 2/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phosphoric Acid SCHEMBL8500180 | 0.93 | ADORA2B (0.43) | ADORA2BADORA2AHTTCYP3A4TSHR | |
| Xanthine SCHEMBL692609 | 0.82 | ADORA2B (0.54) | ADORA2BADORA2ACYP3A4TSHRPDE1A | |
| SCHEMBL6033611 | 0.82 | ADORA2B (0.52) | ADORA2BADORA2AHTT | |
| SCHEMBL272518 | 0.81 | TSHR (0.39) | ADORA2BADORA2AHTTTSHR | |
| SCHEMBL8519588 | 0.81 | TSHR (0.36) | ADORA2BADORA2AHTTCYP3A4TSHR | |
| SCHEMBL2053840 | 0.80 | TSHR (0.35) | ADORA2BADORA2AHTTTSHRMEN1 | |
| SCHEMBL1892013 | 0.77 | POLB (0.49) | ADORA2BADORA2ACYP3A4MEN1KMT2A | |
| SCHEMBL5461564 | 0.76 | ADORA2B (0.51) | ADORA2BADORA2ACYP3A4TSHRBLM | |
| SCHEMBL295965 | 0.75 | POLB (0.66) | CYP3A4TSHRPDE1APDE1BPDE1C | |
| SCHEMBL150603 | 0.75 | GAA (0.45) | CYP3A4TSHRPDE1APDE1BPDE1C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 9997 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025233983-A1 | DRUGS AND COMPOSITIONS FOR USE IN THE TREATMENT OF RETT SYNDROME | UNIVERSITA' DEGLI STUDI DI TRIESTE (IT) | 2025-11-13 | — | — | WO | claimed |
| US-20250325591-A1 | THERAPY FOR HEPATIC DISORDERS USING ADIPOSE-DERIVED MESENCHYMAL STEM CELL LINE | UNIV KEIO (JP) | 2025-10-23 | — | — | US | claimed |
| US-20250283041-A1 | METHODS FOR PRODUCING RED BLOOD CELLS | ALBERT EINSTEIN COLLEGE MEDICINE (US) | 2025-09-11 | — | — | US | claimed |
| US-20250115872-A1 | GENERATION OF BROWN ADIPOCYTES FROM HUMAN PLURIPOTENT STEM CELLS | THE BRIGHAM AND WOMEN'S HOSPITAL, INC. | 2025-04-10 | — | — | US | claimed |
| EP-4532693-A1 | METHODS FOR PRODUCING RED BLOOD CELLS | Albert Einstein College of Medicine (US) | 2025-04-09 | — | — | EP | claimed |
| WO-2025033531-A1 | TREATMENT OF TENDON DISORDERS USING PLATELETS PRODUCED FROM ADIPOSE TISSUE-DERIVED MESENCHYMAL STEM CELL LINE | 慶應義塾 | 2025-02-13 | — | — | WO | claimed |
| US-20240415893-A1 | TREATMENT FOR KNEE OSTEOARTHRITIS USING ADIPOSE TISSUE-DERIVED MESENCHYMAL STEM CELL LINE | KEIO UNIVERSITY (JP) | 2024-12-19 | — | — | US | claimed |
| EP-4473093-A1 | GENERATION OF BROWN ADIPOCYTES FROM HUMAN PLURIPOTENT STEM CELLS | The Brigham and Women's Hospital, Inc. (US) | 2024-12-11 | — | — | EP | claimed |
| CN-118871570-A | Production of brown adipocytes from human pluripotent stem cells | 布里格姆妇女医院 | 2024-10-29 | — | — | CN | claimed |
| EP-4450075-A1 | THERAPY FOR HEPATIC DISORDERS USING ADIPOSE-DERIVED MESENCHYMAL STEM CELL LINE | Keio University (JP) | 2024-10-23 | — | — | EP | claimed |
| WO-1992021981-A1 | METHODS AND COMPOSITIONS FOR THE PREVENTION, DIAGNOSIS, AND TREATMENT OF INFLAMMATORY SEROSAL DISEASE AND RELATED CONDITIONS | BAXTER INTERNATIONAL INC. (US) | 1992-12-10 | — | — | WO | claimed |
| WO-1992015282-A2 | COMPOSITION AND METHOD FOR DELIVERY OF DRUGS | INDIANA UNIVERSITY FOUNDATION (US) | 1992-09-17 | — | — | WO | claimed |
| EP-0308460-B1 | A COMPOSITION FOR THE TOPICAL TREATMENT OF GLAUCOMA OR OCULAR HYPERTENSION | Kabi Pharmacia AB (SE) | 1992-07-29 | — | — | EP | claimed |
| US-5079253-A | COMPOSITION FOR THE TOPICAL TREATMENT OF GLAUCOMA OR OCULAR HYPERTENSION | PHARMACIA AB (SE) | 1992-01-07 | — | — | US | claimed |
| US-4902690-A | SYNERGISTIC COMBINATION OF PHOSPHODIESTERASE INHIBITOR AND OCTOPAMINE AGONIST | THE GENERAL HOSPITAL CORPORATION (US) | 1990-02-20 | — | — | US | claimed |
| EP-0308460-A1 | A COMPOSITION FOR THE TOPICAL TREATMENT OF GLAUCOMA OR OCULAR HYPERTENSION. | PHARMACIA AB (SE) | 1989-03-29 | — | — | EP | claimed |
| US-4800081-A | CALCIUM INFLUX BLOCKER SYNERGISTIC WITH INTERFERON OR CYCLIC NUCLEOTIDE MODULATOR | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1989-01-24 | — | — | US | claimed |
| WO-1988007380-A1 | A COMPOSITION FOR THE TOPICAL TREATMENT OF GLAUCOMA OR OCULAR HYPERTENSION | PHARMACIA AB (SE) | 1988-10-06 | — | — | WO | claimed |
| WO-1987007508-A1 | METHODS AND COMPOSITIONS FOR TREATING VIRAL INFECTIONS | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1987-12-17 | — | — | WO | claimed |
| US-4337254-A | ANTICOAGULANTS COMPRISING A PROSTACYCLIN AND A PHOSPHODIESTERASE INHIBITOR; PREVENTING LOWERING OF BLOOD PRESSURE | BURROUGHS WELLCOME CO. (US) | 1982-06-29 | — | — | US | claimed |